Select Medical Holdings' Sale Approved by Stockholders

By Philip Seaworth • Saturday, June 27 13:01 • Permanent Link

Select Medical Holdings’ stockholders approved the company’s sale to a consortium led by Executive Chairman and co-founder Robert A. Ortenzio, senior executive vice president Martin F. Jackson and Welsh, Carson, Anderson & Stowe.

At the special meeting on June 26, 2026, about 82.54% of Select Medical’s outstanding shares were voted. The merger won approval from more than 79.88% of all outstanding shares and more than 76.64% of the outstanding shares held by stockholders unaffiliated with the consortium.

Select Medical said it expects the transaction to close in mid-2026, subject to the remaining terms of the merger agreement.

The company said it operated 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states and 1,912 outpatient rehabilitation clinics in 37 states and the District of Columbia as of March 31, 2026. That footprint totaled operations in 38 states and the District of Columbia. As a result of these announcements, the company's shares have moved -0.3% on the market, and are now trading at a price of $16.50. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.